Molecular Defects in Cardiovascular Disease (eBook)

A.  Molecular Mechanisms in Heart Disease 1.   Calcium overloading-induced oxidative stress-mediated cellular and subcellular remodelingY. Cheema, A.U. Shahbaz, S.K. Bhattacharya, R.A. Ahokas, Y.Sun, I.C. Gerling and K.T. Weber 2.   Intracellular MMP-2:  Role in normal and diseased heartsN. Youssef and R. Schulz 3.   Control of the mesenchymal-derived cell phenotype by Ski and Meox2: A putative mechanism for post-developmental phenoconversion R.H. Cunnington, J.T. Wigle, J.M. Douville, D.H. Freed, D. Schaafsma, S. O’Connor, S. Gupta, S.G. Rattan, A. Halayko and I.M.C. Dixon 4.   Elevated Na+/H+ exchanger expression and its role in myocardial diseaseL. Fliegel 5.   Impact of perinatal chronic hypoxia on cardiac tolerance to acute ischemia B. Ostadal, I. Ostadalova, F. Kolar, I. Netuka, O. Szarszoi,  6.   Stem cell, microRNA and redox cyclingP. Mukhopadhay, N. Gurusamy and D.K. Das 7.   Cardiac cell therapy: Present and futureD.K. Singla B.  Cardiac Hypertophy and Heart Failure 8.   Macroscopic and microscopic aspects of cardiac dysfunction in congestive heart failure      H.E.D.J. ter Keurs 9.   Cardiac dysfunction and metabolism: Unravelling the molecular cross-talkV. Sharma and J.H. McNeill  10. Metabolic remodeling of the hypertrophied heartJ.M. Dai and M.F. Allard 11. Mechanisms for the regulation of phospholipase C gene expression in cardiac hypertrophyP.S. Tappia  12. Molecular changes in fatty acid oxidation in the failing heartJ.S. Jaswal, W. Keung, W. Wang, J.R. Ussher and G.D. Lopaschuk 13. Cardiolipin metabolism in experimental and human heart failureG.M. Hatch 14. Mechanisms underlying development of cardiomyocyte hypertrophy via Na-H exchange stimulationM. Karmazyn 15. The structural basis of cardiac dysfunction in human heart failureS. Hein, S. Kostin and J. Schaper 16. Hormonal mechanisms of cardiac remodeling in heart failureA.P. Babick, V. Elimban and N.S. Dhalla 17. Modulators of remodeling after myocardial infarctionB.I. Jugdutt 18. Phosphodiesterase-5 inhibitors in protection against doxorubicin-induced cardiomyopathyS. Koka and R.C. Kukreja C.  Hypertension and Diabetes 19. Molecular basis of pulmonary hypertension in left heart failureB. Raj, H.S. Pillai and C.C. Kartha 20. Modulation of Gi protein expression in hypertension: Molecular mechanismsM.B. Anand-Srivastava 21. Vascular dysfunction in heart diseaseR. Perrault and P. Zahradka 22. Cellular and molecular mechanisms associated with salicylate inhibition of intimal hyperplasia balloon catheter-induced vascular injuryS.N. Murthy, P.J. Kadowitz and D.B. McNamara 23. Involvement of growth factor receptor and non receptor protein tyrosine kinases in endothelin 1 and angiotensin II-induced signaling pathways in the cardiovascular system.G. Vardatsikos and A.K. Srivastava 24. Sarco/endoplasmic reticulum Ca2+ pump damage by oxidative stress: Implications for Ca2+ entryG. Akolkar and A.K. Grover 25. Obesity-hypertension: Leptin as the common link to cardiovascular and renal dysregulationS. Kshatriya, H. Kozman, D. Siddiqui, L. Bhatta, K. Liu, A. Salah, T. Ford, R. Michiel, R. Carhart and D. Villarreal 26. Cardiorenal protection in diabetes mellitusH. Vashistha, L.G. Meggs and A. Malhotra 27. Molecular mechanisms in the pathogenesis of diabetic cardiomyopathyS. Chakrabarti